102 related articles for article (PubMed ID: 3827098)
1. [Etiology of insulin-dependent diabetes. Prospects for immunological therapy].
Levy-Marchal C; Czernichow P
Ann Pediatr (Paris); 1986 Dec; 33(10):877-81. PubMed ID: 3827098
[No Abstract] [Full Text] [Related]
2. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
Galenok VA; Zhuk EA
Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069
[No Abstract] [Full Text] [Related]
3. The prospects of immunosuppression in type I diabetes.
Bach JF; Feutren G; Boitard C
Adv Nephrol Necker Hosp; 1988; 17():321-40. PubMed ID: 3124546
[No Abstract] [Full Text] [Related]
4. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
Diem P
Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of insulin-dependent diabetes.
Bell DS; Acton RT
Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
[No Abstract] [Full Text] [Related]
6. Immunointervention in insulin dependent diabetes: implications for the epidemiology of the disease.
Visalli N; Pozzilli P; Boccuni ML; Suppa MA; Messina R; Buzzetti R; Andreani D
Ann Ig; 1992; 4(3):159-63. PubMed ID: 1284515
[No Abstract] [Full Text] [Related]
7. [The pathogenetic characteristics and the possible ways for the pharmacological correction of insulin-dependent diabetes mellitus].
Chernov IuN; Pashkov AN; Vasin MV; Batishcheva GA; Zolotarev DV
Eksp Klin Farmakol; 1999; 62(3):60-6. PubMed ID: 10439953
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppression trials in type I diabetes].
Feutren G; Boitard C; Assan R; Bach JF
Journ Annu Diabetol Hotel Dieu; 1987; ():147-69. PubMed ID: 3302472
[No Abstract] [Full Text] [Related]
9. Immunological features in the course of type 1 diabetes.
Ilonen J; Mustonen A; Akerblom HK; Kouvalainen K
Ann Clin Res; 1984; 16(2):64-73. PubMed ID: 6380389
[No Abstract] [Full Text] [Related]
10. [Immunosuppressive drugs and autoimmune diseases].
Rossert J; Druet P
Ann Biol Clin (Paris); 1991; 49(6):327-37. PubMed ID: 1759727
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppression in juvenile diabetes mellitus? Critical viewpoint on the treatment with cyclosporin A with consideration of the differential etiology].
Teuber J; Usadel KH
Fortschr Med; 1985 Jul; 103(27-28):707-13. PubMed ID: 4029865
[No Abstract] [Full Text] [Related]
12. [Immunological prospects in the treatment of type 1 diabetes mellitus].
Boitard C; Larger E
Rev Prat; 1996 Mar; 46(5):593-7. PubMed ID: 8815526
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective.
Mauricio D; Mandrup-Poulsen T; Nerup J
Diabetes Metab Rev; 1996 Apr; 12(1):57-68. PubMed ID: 8861501
[No Abstract] [Full Text] [Related]
14. Probing the causes of type I diabetes.
Zoler ML
Geriatrics; 1983 Sep; 38(9):121-3. PubMed ID: 6884772
[No Abstract] [Full Text] [Related]
15. Outlook for immune intervention in type I diabetes.
Grob PJ
Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
[No Abstract] [Full Text] [Related]
16. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus].
Galenok VA; Zhuk EA
Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114
[TBL] [Abstract][Full Text] [Related]
17. [Immunointervention in newly diagnosed type 1 diabetes].
Kaupper T; Walter M; Ziegler AG
Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660
[No Abstract] [Full Text] [Related]
18. [Is prevention of diabetes mellitus possible?].
Lehmann R; Spinas GA
Ther Umsch; 1994 Oct; 51(10):693-700. PubMed ID: 7839327
[TBL] [Abstract][Full Text] [Related]
19. [Etiology and pathogenesis of type I diabetes].
Ziegler AG
Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive therapy in type 1 diabetes: update].
Pozzilli P
Recenti Prog Med; 1987 Nov; 78(11):514-6. PubMed ID: 3324237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
